Sotrovimab reduces the severity of COVID-19 progression
1. In patients with mild-to-moderate coronavirus disease 2019 (COVID-19), sotrovimab reduced the risk of disease progression. 2. Sotrovimab was associated ...
1. In patients with mild-to-moderate coronavirus disease 2019 (COVID-19), sotrovimab reduced the risk of disease progression. 2. Sotrovimab was associated ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.